AU5787901A - Compound - Google Patents

Compound

Info

Publication number
AU5787901A
AU5787901A AU57879/01A AU5787901A AU5787901A AU 5787901 A AU5787901 A AU 5787901A AU 57879/01 A AU57879/01 A AU 57879/01A AU 5787901 A AU5787901 A AU 5787901A AU 5787901 A AU5787901 A AU 5787901A
Authority
AU
Australia
Prior art keywords
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57879/01A
Other languages
English (en)
Inventor
John Charles Brennand
Andrew David Charles
Kevin Anthony Hart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU5787901A publication Critical patent/AU5787901A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU57879/01A 1999-12-10 2000-12-05 Compound Abandoned AU5787901A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16994499P 1999-12-10 1999-12-10
US60/169944 1999-12-10
PCT/GB2000/004631 WO2001048483A2 (en) 1999-12-10 2000-12-05 Method for screening of appetite control agents

Publications (1)

Publication Number Publication Date
AU5787901A true AU5787901A (en) 2001-07-09

Family

ID=22617859

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57879/01A Abandoned AU5787901A (en) 1999-12-10 2000-12-05 Compound

Country Status (4)

Country Link
EP (1) EP1240199A2 (ja)
JP (1) JP2003518628A (ja)
AU (1) AU5787901A (ja)
WO (1) WO2001048483A2 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003276106A1 (en) * 2002-10-24 2004-05-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12)
KR20060036466A (ko) * 2003-09-19 2006-04-28 패러다임 테라퓨틱스 리미티드 수용체
CA2605574A1 (en) * 2004-04-20 2005-11-03 Galapagos N.V. Methods, compositions and compound assays for inhibiting amyloid-beta protein production
US8221990B2 (en) 2007-04-06 2012-07-17 Teijin Pharma Limited Screening GPR12 receptor for substances having Nesfatin-1-like action, or which regulate Nesfatin-1 action
CN101808647A (zh) * 2007-05-15 2010-08-18 海利空医疗公司 通过抑制Gpr12治疗认知障碍的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
DK0965041T3 (da) * 1997-04-14 2009-05-25 Arena Pharm Inc Fremgangsmåde til identifikation af modulatorer af celleoverflade-membranreceptorer, som kan anvendes til behandling af sygdomme
EP1071766A4 (en) * 1998-03-23 2004-12-29 Smithkline Beecham Corp HUMAN PROTEIN G COUPLED TO GPR6sb RECEPTOR

Also Published As

Publication number Publication date
JP2003518628A (ja) 2003-06-10
WO2001048483A3 (en) 2002-01-10
WO2001048483A2 (en) 2001-07-05
EP1240199A2 (en) 2002-09-18

Similar Documents

Publication Publication Date Title
AU5413600A (en) Compounds
AU1278701A (en) Novel compounds
AU1173201A (en) Skin-gripper
AUPP999799A0 (en) New compound
AU2408300A (en) Novel compounds
AU1746401A (en) Compounds
AUPQ441499A0 (en) Novel compound
AU6032100A (en) New compounds
AU3997700A (en) Anti-first-pass effect compounds
AU4132200A (en) Novel compounds
AU2109700A (en) Novel compounds
AU5787901A (en) Compound
AU6567400A (en) Substituted 2-imino-thiazolines
AU5119400A (en) Compounds
AU2288900A (en) Novel compounds
AU2668000A (en) Bis-styrylbiphenyl compounds
AU6168900A (en) Compounds
AU1385701A (en) Novel compounds
AU4156800A (en) Novel compounds
AU7784700A (en) Novel compounds
AU6831100A (en) Substituted heterocyclybenzofuranes
AU1737601A (en) Collectalbum
AUPQ357699A0 (en) New compound WF217
AU2194201A (en) Novel compound
AU2292400A (en) Novel compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase